Goldman Sachs Adjusts Siemens Healthineers Target Price While Keeping Buy Recommendation

Thursday, 1 August 2024, 10:07

Goldman Sachs has revised its target price for Siemens Healthineers from 60 to 58 Euros, yet it maintains a 'Buy' rating. This adjustment reflects ongoing challenges within the company but signals confidence in its long-term potential. Investors should consider the implications of this downgrade alongside the firm's positive endorsement.
LivaRava Finance Meta Image
Goldman Sachs Adjusts Siemens Healthineers Target Price While Keeping Buy Recommendation

Goldman Sachs Adjusts Target Price for Siemens Healthineers

The analysis by Jefferies reports a shift in the target price for Siemens Healthineers stock. The new target now stands at 58 Euros, down from the previous estimate of 60 Euros.

Buy Rating Remains

Despite the reduction in target price, Goldman Sachs has retained its 'Buy' classification for this stock. This indicates a belief in the company's capability to deliver positive performance in the future.

  • Revised target price: 58 Euros
  • Previous target price: 60 Euros
  • Current rating: Buy

Conclusion

While the target price adjustment shows caution regarding the challenges faced by Siemens Healthineers, the 'Buy' rating suggests that analysts are still optimistic about its future.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe